A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
Top Cited Papers
Open Access
- 19 May 2006
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 125 (4), 733-747
- https://doi.org/10.1016/j.cell.2006.03.035
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in gliomaCancer Cell, 2006
- The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complexThe Journal of cell biology, 2005
- Phosphoinositide 3-Kinase Catalytic Subunit Deletion and Regulatory Subunit Deletion Have Opposite Effects on Insulin Sensitivity in MiceMolecular and Cellular Biology, 2005
- Deficiency in the Catalytic Subunit of DNA-Dependent Protein Kinase Causes Down-Regulation of ATMCancer Research, 2005
- High Frequency of Mutations of the PIK3CA Gene in Human CancersScience, 2004
- Bisperoxovanadium compounds are potent PTEN inhibitorsFEBS Letters, 2004
- A Function for Phosphoinositide 3-Kinase β Lipid Products in Coupling βγ to Ras Activation in Response to Lysophosphatidic AcidOnline Journal of Public Health Informatics, 2002
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- p110β Is Up-regulated during Differentiation of 3T3-L1 Cells and Contributes to the Highly Insulin-responsive Glucose Transport ActivityOnline Journal of Public Health Informatics, 2000
- cAMP‐dependent protein kinase: Crystallographic insights into substrate recognition and phosphotransferProtein Science, 1994